東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/03/31 | 2,806 | 2,819 | 2,748 | 2,748 | -70 | -2.5% | 61,000 |
2022/03/30 | 2,895 | 2,895 | 2,781 | 2,818 | -70 | -2.4% | 65,500 |
2022/03/29 | 2,902 | 2,923 | 2,868 | 2,888 | -14 | -0.5% | 64,400 |
2022/03/28 | 2,908 | 2,925 | 2,895 | 2,902 | +13 | +0.4% | 56,500 |
2022/03/25 | 2,863 | 2,923 | 2,863 | 2,889 | +36 | +1.3% | 67,500 |
2022/03/24 | 2,883 | 2,894 | 2,836 | 2,853 | -52 | -1.8% | 102,200 |
2022/03/23 | 2,916 | 2,926 | 2,875 | 2,905 | +5 | +0.2% | 61,800 |
2022/03/22 | 2,900 | 2,942 | 2,890 | 2,900 | +30 | +1% | 93,400 |
2022/03/18 | 2,870 | 2,885 | 2,858 | 2,870 | -19 | -0.7% | 57,600 |
2022/03/17 | 2,908 | 2,920 | 2,869 | 2,889 | +19 | +0.7% | 85,300 |
2022/03/16 | 2,901 | 2,910 | 2,870 | 2,870 | -28 | -1% | 55,100 |
2022/03/15 | 2,853 | 2,909 | 2,840 | 2,898 | +50 | +1.8% | 54,900 |
2022/03/14 | 2,830 | 2,873 | 2,822 | 2,848 | +43 | +1.5% | 47,500 |
2022/03/11 | 2,778 | 2,825 | 2,772 | 2,805 | -18 | -0.6% | 68,400 |
2022/03/10 | 2,734 | 2,824 | 2,729 | 2,823 | +121 | +4.5% | 70,200 |
2022/03/09 | 2,730 | 2,731 | 2,695 | 2,702 | -19 | -0.7% | 48,300 |
2022/03/08 | 2,749 | 2,777 | 2,707 | 2,721 | -28 | -1% | 54,900 |
2022/03/07 | 2,756 | 2,781 | 2,724 | 2,749 | -81 | -2.9% | 94,500 |
2022/03/04 | 2,808 | 2,856 | 2,794 | 2,830 | +22 | +0.8% | 66,200 |
2022/03/03 | 2,814 | 2,846 | 2,794 | 2,808 | +8 | +0.3% | 64,900 |
2022/03/02 | 2,765 | 2,815 | 2,751 | 2,800 | -44 | -1.5% | 104,000 |
2022/03/01 | 2,922 | 2,954 | 2,842 | 2,844 | -128 | -4.3% | 102,000 |
2022/02/28 | 2,930 | 2,983 | 2,920 | 2,972 | +38 | +1.3% | 59,400 |
2022/02/25 | 2,961 | 2,985 | 2,921 | 2,934 | -20 | -0.7% | 39,500 |
2022/02/24 | 2,922 | 2,972 | 2,922 | 2,954 | +42 | +1.4% | 63,400 |
2022/02/22 | 2,935 | 2,971 | 2,891 | 2,912 | -93 | -3.1% | 65,900 |
2022/02/21 | 3,080 | 3,080 | 3,000 | 3,005 | -115 | -3.7% | 51,900 |
2022/02/18 | 3,100 | 3,135 | 3,075 | 3,120 | +20 | +0.6% | 68,500 |
2022/02/17 | 3,075 | 3,130 | 3,070 | 3,100 | +20 | +0.6% | 101,900 |
2022/02/16 | 3,030 | 3,085 | 2,982 | 3,080 | +20 | +0.7% | 150,900 |
2022/02/15 | 2,940 | 3,090 | 2,900 | 3,060 | +170 | +5.9% | 198,800 |
2022/02/14 | 2,900 | 2,915 | 2,869 | 2,890 | -19 | -0.7% | 80,200 |
2022/02/10 | 2,929 | 2,939 | 2,879 | 2,909 | -23 | -0.8% | 65,600 |
2022/02/09 | 2,871 | 2,938 | 2,851 | 2,932 | +51 | +1.8% | 54,600 |
2022/02/08 | 2,940 | 2,940 | 2,875 | 2,881 | -49 | -1.7% | 33,200 |
2022/02/07 | 2,920 | 2,930 | 2,892 | 2,930 | +36 | +1.2% | 56,900 |
2022/02/04 | 2,853 | 2,905 | 2,847 | 2,894 | +24 | +0.8% | 79,100 |
2022/02/03 | 2,879 | 2,896 | 2,856 | 2,870 | -16 | -0.6% | 36,000 |
2022/02/02 | 2,848 | 2,887 | 2,823 | 2,886 | +58 | +2.1% | 44,300 |
2022/02/01 | 2,800 | 2,846 | 2,796 | 2,828 | +28 | +1% | 59,800 |
2022/01/31 | 2,717 | 2,810 | 2,717 | 2,800 | +64 | +2.3% | 79,800 |
2022/01/28 | 2,716 | 2,753 | 2,707 | 2,736 | +70 | +2.6% | 43,900 |
2022/01/27 | 2,737 | 2,752 | 2,653 | 2,666 | -67 | -2.5% | 73,700 |
2022/01/26 | 2,785 | 2,785 | 2,727 | 2,733 | -24 | -0.9% | 30,700 |
2022/01/25 | 2,724 | 2,769 | 2,706 | 2,757 | +2 | +0.1% | 63,500 |
2022/01/24 | 2,717 | 2,767 | 2,707 | 2,755 | +33 | +1.2% | 38,700 |
2022/01/21 | 2,714 | 2,728 | 2,668 | 2,722 | +27 | +1% | 43,200 |
2022/01/20 | 2,695 | 2,721 | 2,672 | 2,695 | ±0 | ±0% | 60,600 |
2022/01/19 | 2,720 | 2,739 | 2,680 | 2,695 | -102 | -3.6% | 97,500 |
2022/01/18 | 2,886 | 2,892 | 2,789 | 2,797 | -86 | -3% | 78,100 |
651~
700
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム